Eagle Pharmaceuticals Inc (EGRX) has shared an update.
Brian Cahill stepped down as CFO of Eagle Pharmaceuticals, and Steven Ratoff, a Board member, was appointed as the Interim CFO. Ratoff brings a wealth of experience from various leadership roles, including CEO positions at specialty pharmaceutical companies. The company is compensating Cahill for his continued consulting services during a six-month transition period. Meanwhile, Ratoff’s interim position comes with a defined compensation structure, but excludes him from the company’s executive bonus and severance plans. Additionally, the company has discontinued the consulting services of its former CEO, Scott Tarriff.
See more data about EGRX stock on TipRanks’ Stock Analysis page.
